Clinical trials
Recruiting Phase 3 trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
230 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 16 |
| 2023 | 20 |
| 2024 | 45 |
| 2025 | 84 |
| 2026 | 47 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 230 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 21 |
| Merck Sharp & Dohme LLC | 14 |
| Eli Lilly and Company | 11 |
| Janssen Research & Development, LLC | 10 |
| Boehringer Ingelheim | 9 |
| Novartis Pharmaceuticals | 7 |
| Takeda | 7 |
| Incyte Corporation | 6 |
| Amgen | 5 |
| Hoffmann-La Roche | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 21 |
| Crohn Disease | 9 |
| Leukemia, Myeloid, Acute | 8 |
| Multiple Myeloma | 8 |
| Heart Failure | 7 |
| Neoplasms | 6 |
| Obesity | 6 |
| Lung Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Small Cell Lung Carcinoma | 5 |
Trials
Showing 1 to 25 of 230. Each trial links to its page on Pharma Observatory.
130 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.